메뉴 건너뛰기




Volumn 348, Issue 9041, 1996, Pages 1531-1532

New frontiers of immunotherapy for HIV

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CYTOKINE; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

EID: 0029845293     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)66165-X     Document Type: Note
Times cited : (6)

References (10)
  • 1
    • 1842266562 scopus 로고    scopus 로고
    • HIV viral load markers in clinical practice
    • MS Saag M Holodniy DR Kuritzkes HIV viral load markers in clinical practice Nat Med 2 1996 625 629
    • (1996) Nat Med , vol.2 , pp. 625-629
    • Saag, MS1    Holodniy, M2    Kuritzkes, DR3
  • 2
    • 0000302748 scopus 로고    scopus 로고
    • AIDS is not caused by the extreme genetic variability of HIV
    • E Pelletier S Wain-Hobson AIDS is not caused by the extreme genetic variability of HIV J NIH Res 8 1996 45 49
    • (1996) J NIH Res , vol.8 , pp. 45-49
    • Pelletier, E1    Wain-Hobson, S2
  • 3
    • 0029417004 scopus 로고
    • Identification of RANTES, MIP-1alpha and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells
    • F Cocchi AL DeVico A Garzino-Demo Identification of RANTES, MIP-1alpha and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells Science 270 1995 1811 1815
    • (1995) Science , vol.270 , pp. 1811-1815
    • Cocchi, F1    DeVico, AL2    Garzino-Demo, A3
  • 4
    • 0005014748 scopus 로고    scopus 로고
    • The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
    • H Choe M Farzon Y Sun The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates Cell 85 1996 1135 1148
    • (1996) Cell , vol.85 , pp. 1135-1148
    • Choe, H1    Farzon, M2    Sun, Y3
  • 5
    • 0030002637 scopus 로고    scopus 로고
    • HIV-1 entry co-factor: functional cDNA cloning of seven-transmembrane, G-protein-compled receptor
    • Y Feng CC Broder RE Kennedy EA Berger HIV-1 entry co-factor: functional cDNA cloning of seven-transmembrane, G-protein-compled receptor Science 272 1996 872 877
    • (1996) Science , vol.272 , pp. 872-877
    • Feng, Y1    Broder, CC2    Kennedy, RE3    Berger, EA4
  • 6
    • 15844388931 scopus 로고    scopus 로고
    • Homozygous defect in HIV-1co-receptor accounts for resistance of some multiply exposed individuals to HIV infection
    • R Liu WA Paxton S Choe Homozygous defect in HIV-1co-receptor accounts for resistance of some multiply exposed individuals to HIV infection Cell 86 1996 367 377
    • (1996) Cell , vol.86 , pp. 367-377
    • Liu, R1    Paxton, WA2    Choe, S3
  • 7
    • 0001633495 scopus 로고    scopus 로고
    • Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene
    • M Dean M Carrington C Winkler Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene Science 273 1996 1856 1862
    • (1996) Science , vol.273 , pp. 1856-1862
    • Dean, M1    Carrington, M2    Winkler, C3
  • 8
    • 0030593031 scopus 로고    scopus 로고
    • Toward an understanding of the correlates of protective immunity to HIV infection
    • BF Haynes G Panteleo AS Fauci Toward an understanding of the correlates of protective immunity to HIV infection Science 271 1996 324 328
    • (1996) Science , vol.271 , pp. 324-328
    • Haynes, BF1    Panteleo, G2    Fauci, AS3
  • 9
    • 0030571189 scopus 로고    scopus 로고
    • HIV vaccines: where we are and where are we going
    • BF Haynes HIV vaccines: where we are and where are we going Lancet 348 1996 933 937
    • (1996) Lancet , vol.348 , pp. 933-937
    • Haynes, BF1
  • 10
    • 10144226387 scopus 로고    scopus 로고
    • Viral load, CD4 percentage, and delayed-type hypersensitivity in subjects receiving HIV-1 immunogen and anti-viral drug therapy
    • RB Moss F Ferre A Leviue Viral load, CD4 percentage, and delayed-type hypersensitivity in subjects receiving HIV-1 immunogen and anti-viral drug therapy J Clin Immunol 16 1996 266 270
    • (1996) J Clin Immunol , vol.16 , pp. 266-270
    • Moss, RB1    Ferre, F2    Leviue, A3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.